Page 16 - Flipbook
P. 16
TITAN: Apalutamide in All-Comer mCSPC
100
82%
Patients Who Were Alive (%)
Apalutamide + ADT
75
74%
Placebo + ADT
50
25
HR (95% CI) 0.67 (0.51-0.89)
P value 0.0053
0
0 6 12 18 24 30 36
No. at risk Months
Apalutamide 525 513 490 410 165 14 0
Placebo 527 509 473 387 142 16 0
Kim N. Chi, MD
